Sun Yonghong, Xu Yahong, Xu Jie, Lu Dan, Wang Jianyu
Department of General Surgery, No. 2 People's Hospital of Wuxi Jiangsu, 214000, China.
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9081-8. eCollection 2015.
The purpose of this study was to investigate the effect of transmembrane-4-l-six-family-1 (TM4SF1) on breast cancer cell line MDA-MB-231 invasion and apoptosis and its mechanism through PI3K/AKT/mTOR pathway.
siRNA-TM4SF1 and pcDNA-TM4SF1 plasma were constructed and then transfected into MDA-MB-231 cells respectively. Real time (RT)-PCR was used to measure the mRNA expression of TM4SF1 in each group. Also, matrigel method and Annexin V-FITC were used to detect the effect of TM4SF1 expression on MDA-MB-231 cell migration and apoptosis respectively. Besides, western blotting analyze was used to assay the effects of TM4SF1 expression on PI3K/AKT/mTOR pathway associated proteins expressions.
The results showed that after being transfected with siRNA-TM4SF1, TM4SF1 expression was significantly declined, while it was significantly increased after cells were transfected with pcDNA-TM4SF1 (P<0.05). Compared with the controls, TM4SF1 overexpression significantly contributed MDA-MB-231 cell migration but decreased apoptotic cells (P<0.05), which were opposite to the results when TM4SF1 was sliced in cells. Moreover, TM4SF1 slicing significantly decreased the expressions of phosphorylated (p)-AKT, p-mTOR, and p-P70 (P<0.05).
Our study suggested that TM4SF1 may be a therapeutic target for breast cancer treatment and may loan insight into the mechanisms behind the development and metastasis of advanced breast cancer.
本研究旨在探讨跨膜4L6家族成员1(TM4SF1)对乳腺癌细胞系MDA-MB-231侵袭和凋亡的影响及其通过PI3K/AKT/mTOR通路的作用机制。
构建siRNA-TM4SF1和pcDNA-TM4SF1质粒,然后分别转染至MDA-MB-231细胞。采用实时定量聚合酶链反应(RT-PCR)检测各组TM4SF1的mRNA表达。此外,利用基质胶法和膜联蛋白V-异硫氰酸荧光素(Annexin V-FITC)分别检测TM4SF1表达对MDA-MB-231细胞迁移和凋亡的影响。另外,采用蛋白质免疫印迹分析检测TM4SF1表达对PI3K/AKT/mTOR通路相关蛋白表达的影响。
结果显示,转染siRNA-TM4SF1后,TM4SF1表达显著下降,而转染pcDNA-TM4SF1后,其表达显著增加(P<0.05)。与对照组相比,TM4SF1过表达显著促进MDA-MB-231细胞迁移,但减少凋亡细胞(P<0.05),这与TM4SF1基因敲低时的结果相反。此外,TM4SF1基因敲低显著降低磷酸化(p)-AKT、p-mTOR和p-P70的表达(P<0.05)。
我们的研究表明,TM4SF1可能是乳腺癌治疗的一个靶点,可能为晚期乳腺癌的发生和转移机制提供见解。